Adia Med, Inc. (ADIA) stock

ADIAOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 1/30

$0.13−0.01 (-7.14%)

Close on Oct 19, 2026Market cap $20.98MP/E –Yield –

Adia Med r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2025 it was $29.14K.

Period	Period end	Value	Change
FY2025	Dec 31, 2025	$29.14K	–
FY2024	Dec 31, 2024	$0	–

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q2 FY2026	Jun 30, 2026	$0	–
Q2 FY2025	Jun 30, 2025	$24.62K	–

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ADIA.

Revenue growth10879.7% · median 4.2%

Gross margin27.4% · median 66.4%

Operating margin-52.3% · median -2180.9%

Net margin-56.5% · median -1932.8%

Advertisement
300 × 250

See a number that looks wrong?